SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer Journal Article


Authors: Li, L.; Shen, C.; Nakamura, E.; Ando, K.; Signoretti, S.; Beroukhim, R.; Cowley, G.; Lizotte, P.; Liberzon, E.; Bair, S.; Root, D.; Tamayo, P.; Tsherniak, A.; Cheng, S. C.; Tabak, B.; Jacobsen, A.; Hakimi, A.; Schultz, N.; Ciriello, G.; Sander, C.; Hsieh, J.; Kaelin, W.
Article Title: SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer
Abstract: Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer and is often linked to loss of chromosome 3p, which harbors the VHL tumor suppressor gene, loss of chromosome 14q, which includes HIF1A, and gain of chromosome 5q. The relevant target(s) on chromosome 5q is not known. Here, we show that 5q amplification leads to overexpression of the SQSTM1 oncogene in ccRCC lines and tumors. Overexpression of SQSTM1 in ccRCC lines promoted resistance to redox stress and increased soft agar growth, while downregulation of SQSTM1 decreased resistance to redox stress, impaired cellular fitness, and decreased tumor formation. Therefore, the selection pressure to amplify 5q in ccRCC is driven, at least partly, by SQSTM1. © 2013 Elsevier Inc.
Journal Title: Cancer Cell
Volume: 24
Issue: 6
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2013-12-09
Start Page: 738
End Page: 750
Language: English
DOI: 10.1016/j.ccr.2013.10.025
PROVIDER: scopus
PMCID: PMC3910168
PUBMED: 24332042
DOI/URL:
Notes: Export Date: 3 February 2014 -- CODEN: CCAEC -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James J Hsieh
    125 Hsieh
  2. Chris Sander
    210 Sander
  3. Nikolaus D Schultz
    486 Schultz
  4. Abraham Ari Hakimi
    324 Hakimi